Anna Eslami

Anna Eslami is a seasoned marketing professional with extensive experience in the life sciences sector, currently serving as the Global Segment Marketing Lead for Reproductive Health at Illumina since 2020. Eslami has spearheaded successful global marketing campaigns, notably for the VeriSeq NIPT Solution v2 and the NovaSeq 550Dx NGS, resulting in significant revenue generation across over 40 countries. Previously, Eslami held various roles at Inova Diagnostics, contributing to the launch of innovative autoimmune testing systems and building strong relationships with key opinion leaders. Eslami’s career also includes significant roles at Merck Life Science, MilliporeSigma, Beckman Coulter Diagnostics, and Gundersen Health System, showcasing a strong foundation in both scientific research and marketing strategy. Eslami holds a Master of Science in Clinical Microbiology, a Bachelor of Science in Genetics and Cell Biology, and a Master of Business Administration.